Tag: Influenza

Sanofi: FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older

Originally published on Sanofi.com. The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 years of age and older. Fluzone® High-Dose (Influenza Vaccine) was approved by the FDA in 2009 as a trivalent influenza vaccine, including two…

Johnson & Johnson Announces Collaboration with U.S. Department of Health and Human Services to Fight Influenza

Johnson & Johnson (No. 5 on the DiversityInc Top 50 Companies list)announced that Janssen Research & Development LLC (Janssen) are collaborating with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) to develop a comprehensive portfolio of therapeutics and vaccines to…